MedTrace Logo

Minocycline as Neuroprotectant After Aneurysmal Subarachnoid Hemorrhage

NCT02113176 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2025-07-22

No results posted yet for this study

Summary

The purpose of this study is to determine the safety and efficacy of a drug minocycline in improving outcomes at 3 months after rupture of an aneurysm in the head.

Conditions

  • Subarachnoid Aneurysm Hemorrhage

Interventions

DRUG

Minocycline

Sponsors & Collaborators

  • University at Buffalo Neurosurgery

    collaborator OTHER

  • University at Buffalo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2016-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02113176 on ClinicalTrials.gov